(Q46921582)

English

Lanthanum carbonate

scientific article published on 31 January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16449551

1 reference

Europe PubMed Central

Lanthanum carbonate. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16449551

author name string

Melanie S Joy

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16449551

Abhijit Kshirsagar

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16449551

Corina Candiani

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16449551

Tyson Brooks

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16449551

Joanna Q Hudson

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16449551

language of work or name

0 references

publication date

31 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16449551

Annals of Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16449551

40

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16449551

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16449551

234-240

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16449551

Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G224

21 January 2018

Strategies to minimize bone disease in renal failure

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G224

21 January 2018

Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G224

21 January 2018

Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study).

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G224

21 January 2018

First International Summit on Kidney Disease Prevention, 25-27 July 2002: consensus document

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G224

21 January 2018

Intestinal absorption of aluminium in renal failure.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G224

21 January 2018

Short-term, high-dose pamidronate-induced acute tubular necrosis: the postulated mechanisms of bisphosphonate nephrotoxicity

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G224

21 January 2018

Control of serum phosphate by oral lanthanum carbonate in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis in a short-term, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G224

21 January 2018

Lanthanum carbonate: a new phosphate binder

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G224

21 January 2018

A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G224

21 January 2018

Localization of lanthanum in bone of chronic renal failure rats after oral dosing with lanthanum carbonate

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G224

21 January 2018

Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G224

21 January 2018

Reducing high phosphate levels in patients with chronic renal failure undergoing dialysis: a 4-week, dose-finding, open-label study with lanthanum carbonate

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G224

21 January 2018

A long-term, open-label extension study on the safety of treatment with lanthanum carbonate, a new phosphate binder, in patients receiving hemodialysis

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G224

21 January 2018

Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure?

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G224

21 January 2018

Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonate

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G224

21 January 2018

Long-term efficacy and tolerability of lanthanum carbonate: results from a 3-year study

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G224

21 January 2018

Identifiers

10.1345/APH.1G224

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16449551

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16449551

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46921582&oldid=2137929640"